SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
32 hedge funds and large institutions have $16.5M invested in Sigilon Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
Holders
32
Holding in Top 10
1
Calls
$27K
Puts
$1K
Top Buyers
| 1 | +$202K | |
| 2 | +$43.5K | |
| 3 | +$40.4K | |
| 4 |
Jane Street
New York
|
+$29.3K |
| 5 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$23.8K |
Top Sellers
| 1 | -$82.2K | |
| 2 | -$24.5K | |
| 3 | -$15.3K | |
| 4 |
BlackRock
New York
|
-$12.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$11.7K |